Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in SEER — Seer, Inc.

CIK 1214717 BOSTON, MA
Back to SEER Full portfolio

Position in SEER

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$764,312
+$53,711 QoQ
Shares Held
460,430
+8.9% QoQ
Ownership
0.832%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 59 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SEER Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. SEER ranks #332 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in SEER

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $764,312 460,430
2026-03-31 $710,601 422,977
2025-12-31 $865,663 473,040
2025-09-30 $1,026,704 473,136
2025-06-30 $1,090,815 509,727
2025-03-31 $739,310 437,462
2024-12-31 $997,702 431,906
2024-09-30 $879,267 446,329
2024-06-30 $707,829 421,327
2024-03-31 $2,060,664 1,084,560
2023-12-31 $2,059,954 1,061,832
2023-09-30 $2,243,488 1,015,153
2023-06-30 $4,196,983 982,900
2023-03-31 $3,328,748 862,370
2022-12-31 $4,877,939 841,024
2022-09-30 $6,154,894 795,206
2022-06-30 $7,143,147 798,117
2022-03-31 $10,940,994 717,913
2021-12-31 $15,935,157 698,604
2021-09-30 $23,265,657 673,781
2021-06-30 $8,810,510 268,777
2021-03-31 $12,677,518 253,449
2020-12-31 $2,191,649 39,039